This activity is designed to educate health care professionals about the latest advances in treatment for renal cell carcinoma.show all
|Category:||Pharmacology , Nursing , Internal Medicine|
|21 days to the end of the display (June 17 2018)|
Release Date: November 20, 2017
Expiration Date: November 20, 2018
Assistant Professor of Medicine
Weill Cornell Medicine
New York, New York
Assistant Professor of Medicine
Harvard Medical School
This activity is designed to educate health care professionals about the latest advances in treatment for renal cell carcinoma.
At the completion of this activity, participants should be better prepared to:
Estimated Time for Completion
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Applied Clinical Education. Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Method of Participation
To receive CME credit, participants should read the monograph and complete the pre-test, posttest, and activity evaluation. CME certificates will be made available immediately upon successful completion.
Disclosure of Conflicts of Interest
Global Education Group requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest they may have as related to the content of this activity. All identified conflicts of interest are vetted thoroughly by Global Education Group for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this activity:
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this activity:
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group and Applied Clinical Education do not recommend the use of any agent outside of the labeled indications. The opinions expressed in this activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or courses of diagnosis or treatment discussed should not be used by clinicians without evaluation of patient conditions, contraindications, applicable manufacturer’s product information, and the recommendations of other authorities.
Accreditor Contact Information
For information about the accreditation of this program, please contact Global Education Group at (303) 395-1782 or firstname.lastname@example.org.